Impact Factor
4.06
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.01
4,266 total citations
h5-index
51
h5 depth signal
Cited share
84.4%
976 of 1,157
Total citations
4,266
Citation footprint
Metric signal
3.89
External metric anchor
Self-citation
2.4%
101 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
2,048
United States
468
Japan
390
United Kingdom
233
Germany
192
Citing Fields of Research
Respiratory Support
1,184
Allergies
1,128
Lung Cancer
1,115
Auto-Inflammatory Disorders
698
Mycobacterial Diseases
233
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
5,426
Articles tracked across the journal lifetime
Indexed publication set
1,157
976 cited publications
Last 12 months
837
69.8 publications/month
Open access share
100.0%
837 OA publications in the last year
Leading citing country
China
2,048 citing publications
Leading citing field
Respiratory Support
1,184 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v5, 2005-
v1n1, 2001-
Active Coverage
Research Focus & Classification
Indexed Subjects
Lung Cancer
Allergies
Respiratory Support
Auto-Inflammatory Disorders
Broad Categories
Pulmonary Medicine
Allergies
Auto-Inflammatory Disorders
Lung Cancer
Respiratory Support
Virology
MeSH Descriptors
Lung Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
DOI 10.1186/s12890-026-04838-3
Open DOI
Different airflow obstruction severity grading methods and mortality: results from the UK Biobank study
04
DOI 10.1186/s12890-026-04799-7
Open DOI
The early warning value of pulmonary fractional flow reserve combined with serological markers in the diagnosis of arterial pulmonary hypertension in Beagle dogs
Background: Arterial pulmonary arterial hypertension (PAH) is a type of pulmonary circulation disease characterized primarily by progressive increase in pulmonary vascular resistance and progressive remodeling of pulmonary small arteries...
05
DOI 10.1186/s12890-026-04831-w
Open DOI
The underlying cause of the destroyed lung is changing: a clinico-radiological study
Background: A destroyed lung (DL) is the complete destruction of the lung due to chronic infections, particularly tuberculosis (TB). To diagnose DL, one must demonstrate radiologically significant damage to the lung, in addition to clini...
06
DOI 10.1186/s12890-026-04835-6
Open DOI
Validation of the Global Lung Function Initiative Spirometry Reference Equations in Tanzania
Background: Spirometry is the most widely used pulmonary function test. Lung function varies with age, sex, height, and ethnicity, therefore accurate interpretation requires comparison with appropriate reference values from healthy indiv...
07
08
DOI 10.1186/s12890-026-04854-3
Open DOI
Short-term sulfur dioxide exposure, rs2516049, and lung function phenotypes in childhood asthma
09
DOI 10.1186/s12890-026-04855-2
Open DOI
Associations between non-insulin-based insulin resistance surrogates and pulmonary hypertension due to left heart failure: a multicenter cohort study
Background: Insulin resistance (IR) has been reported to have a close relationship with the development and adverse outcomes of various cardiovascular disorders, while its association with pulmonary hypertension due to left heart failure...
10
Bibliographical & Catalog Notes
Title from BioMed Central archive volume screen (viewed on Feb. 20, 2002).
Articles are added consecutively to the current annual v.
Articles in PDF and HTML format.
System requirements: HTML browser, JPeg compatible browser or image viewer, Adobe acrobat reader.
Mode of access: Internet.